Abstract:Background: Hyperhomocysteinemia (HHcy) is related to liver diseases, such as nonalcoholic fatty liver (NAFL). Although the precise pathogenesis of NAFL is still largely unknown, the links between organs seem to play a vital role. The current study aimed to explore the role of white adipose tissue in homocysteine (Hcy)-induced NAFL. Methods: Blood samples from nonhyperhomocysteinemia or hyper-homocysteinemia individuals were collected to assess correlation between Hcy and TG or FFAs levels. C57BL/6 mice were maintained on a high-methionine diet or administered with Hcy (1.8 g/l) in the drinking water to establish an HHcy mouse model. Lipolytic response was measured in adipose tissue or 3T3L-1 cells. Hif1a∆adipo mice and lentivirus construction were employed for mechanistic studies. Findings: We demonstrated that Hcy activated adipocyte lipolysis and that this change was accompanied by an increased release of fatty acids (FAs) and glycerol. Excessive FAs were taken up by hepatocyte, which resulted in lipid accumulation in the liver. Treatment with acipimox (0.08 g kg −1 day−1), a potent chemical inhibitor of lipolysis, markedly decreased the Hcy-induced NAFL. Mechanistically, hypoxia-inducible factor 1α (HIF1α)-endoplasmic reticulum oxidoreductin 1α (ERO1α) mediated pathway promoted ROS accumulation and induced ER overoxidation, ER stress and more closed ER-lipid droplet interactions, which were responsible for activating the lipolysis response. Specific disruption of adipocyte HIF1α reversed Hcy-induced lipolysis and alleviated the excess hepatic TG content. Interpretation: This study reveals that Hcy activates lipolysis via adipocyte HIF1α-ERO1α-mediated pathway and suggests the potential utility of targeted adipocyte HIF1α inhibition for treating Hcy-induced NAFL. Funding Statement: This work was supported by the National Natural Science Foundation of the People’s Republic of China (No. 31872787, 91739303, 91857115, 31925021, and 31771261) and the Youth Innovation Promotion Association, CAS (to LW). Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: Plasma was obtained from 38 individuals with hyperhomocysteinemia and 52 nonhyperhomocysteinemia from Peking University Third Hospital and was approved by the Ethics Committee of Peking University Third Hospital. Informed consent prior to participation was provided by all subjects. All animal studies were performed in compliance with the guidelines of the Institute of Laboratory Animal Resources and were approved by the Animal Care and Use Committee of Peking University.

Adipose Tissue Deficiency of Hormone-Sensitive Lipase Causes Fatty Liver in Mice.

Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

Spontaneous Development of Hepatosteatosis in Perilipin-1 Null Mice with Adipose Tissue Dysfunction.

Adipogenic Changes of Hepatocytes in a High-Fat Diet-Induced Fatty Liver Mice Model and Non-Alcoholic Fatty Liver Disease Patients

Fat-1 Mice Prevent High-Fat Plus High-Sugar Diet-Induced Non-Alcoholic Fatty Liver Disease

<strong><b></b></strong>Impaired Adipose Tissue Expansion Caused by LXR Activation is Associated with Insulin Resistance in HFD Mice

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

Molecular Mechanism of Age-Specific Hepatic Lipid Accumulation in PPARα (+/−): LDLR (+/−) Mice, an Obese Mouse Model

Fatty Acids Promote Fatty Liver Disease Via the Dysregulation of 3-Mercaptopyruvate Sulfurtransferase/hydrogen Sulfide Pathway.

Adipose-Specific Deficiency of Fumarate Hydratase in Mice Protects Against Obesity, Hepatic Steatosis, and Insulin Resistance

The Dysfunction of Hormone-Sensitive Lipase Induces Lipid Deposition and Reprogramming of Nutrient Metabolism in Fish.

Ectopic Lipid Deposition Mediates Insulin Resistance in Adipose Specific 11Β-Hydroxysteroid Dehydrogenase Type 1 Transgenic Mice.

Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet

Homocysteine Promotes Hepatic Steatosis by Activating the Adipocyte HIF1α-ERO1α-Lipolysis Pathway

Deficiency of Cystathionine Gamma-Lyase and Hepatic Cholesterol Accumulation During Mouse Fatty Liver Development

Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH

Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition

Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice

Lack of SIRT1 (mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/- Mice: a Role of Lipid Mobilization and Inflammation.

Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance